YU4602A - Farmaceutske formulacije zaštićene od dejstva mikroorganizama - Google Patents

Farmaceutske formulacije zaštićene od dejstva mikroorganizama

Info

Publication number
YU4602A
YU4602A YU4602A YUP4602A YU4602A YU 4602 A YU4602 A YU 4602A YU 4602 A YU4602 A YU 4602A YU P4602 A YUP4602 A YU P4602A YU 4602 A YU4602 A YU 4602A
Authority
YU
Yugoslavia
Prior art keywords
pharmaceutical formulations
preserved pharmaceutical
phenoxyethanol
alone
combination
Prior art date
Application number
YU4602A
Other languages
English (en)
Inventor
Atef Gayed
Original Assignee
Aventis Pharmaceuticals Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharmaceuticals Inc. filed Critical Aventis Pharmaceuticals Inc.
Publication of YU4602A publication Critical patent/YU4602A/sh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Ovaj pronalazak se odnosi na upotrebu benzetonijumhlorida, samog ili u kombinaciji sa fenoksietanolom ili feniletilalkoholom, koja farmaceutskim preparatima daje antimikrobnu aktivnost. Ovaj pronalazak takodje daje postupke za upotrebu benzetonijumhlorida, samog ili u kombinaciji sa fenoksietanolom ili feniletilalkoholom, za inhibiranje rasta mikroba u farmaceutskim preparatima.[The present invention is directed to the use of the benzethonium chloride, alone or in combination with phenoxyethanol or phenyl ethyl alcohol, to provide anti-microbial activity in pharmaceutical compositions. The present invention also provides methods of using benzethonium chloride, alone or in combination with phenoxyethanol or phenyl ethyl alcohol, to inhibit microbial growth in pharmaceutical compositions.
YU4602A 1999-07-22 2000-07-21 Farmaceutske formulacije zaštićene od dejstva mikroorganizama YU4602A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US22881599P 1999-07-22 1999-07-22

Publications (1)

Publication Number Publication Date
YU4602A true YU4602A (sh) 2005-06-10

Family

ID=22858657

Family Applications (1)

Application Number Title Priority Date Filing Date
YU4602A YU4602A (sh) 1999-07-22 2000-07-21 Farmaceutske formulacije zaštićene od dejstva mikroorganizama

Country Status (21)

Country Link
US (1) US7109161B1 (sh)
EP (1) EP1200128A1 (sh)
JP (1) JP2003520777A (sh)
KR (2) KR20020032534A (sh)
CN (1) CN1371287A (sh)
AU (1) AU777410C (sh)
BR (1) BR0012674A (sh)
CA (1) CA2378892C (sh)
CZ (1) CZ2002265A3 (sh)
EA (1) EA007070B1 (sh)
EE (1) EE200200038A (sh)
HK (1) HK1050317A1 (sh)
HR (1) HRP20020160A2 (sh)
HU (1) HUP0202235A3 (sh)
IL (1) IL147756A (sh)
NO (1) NO20020304L (sh)
NZ (1) NZ516736A (sh)
PL (1) PL353026A1 (sh)
WO (1) WO2001007086A1 (sh)
YU (1) YU4602A (sh)
ZA (1) ZA200200743B (sh)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001007086A1 (en) 1999-07-22 2001-02-01 Aventis Pharmaceuticals, Inc. Preserved pharmaceutical formulations
US20020107469A1 (en) * 2000-11-03 2002-08-08 Charles Bolan Apheresis methods and devices
DE60318938T2 (de) 2002-03-20 2009-01-22 Mannkind Corp., Valencia Inhalationsgerät
WO2005044199A2 (en) * 2003-11-05 2005-05-19 Santarus, Inc. Combination of proton pump inhibitor and sleep aid
DE202004020676U1 (de) * 2004-03-10 2005-11-10 Bioceuticals Arzneimittel Ag Erythropoietin-Flüssigformulierung
US8338648B2 (en) * 2004-06-12 2012-12-25 Signum Biosciences, Inc. Topical compositions and methods for epithelial-related conditions
EP1786784B1 (en) 2004-08-20 2010-10-27 MannKind Corporation Catalysis of diketopiperazine synthesis
CA2578175C (en) 2004-08-23 2014-10-14 Mannkind Corporation Diketopiperazine salts, diketomorpholine salts or diketodioxane salts for drug delivery
US9028852B2 (en) 2004-09-07 2015-05-12 3M Innovative Properties Company Cationic antiseptic compositions and methods of use
US7803404B2 (en) 2005-09-14 2010-09-28 Mannkind Corporation Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces
BRPI0707991B8 (pt) 2006-02-22 2021-05-25 Mannkind Corp métodos de preparação de um medicamento em pó seco com uma propriedade farmacêutica melhorada, dito pó seco e uso de uma quantidade efetiva do pó seco
US7612102B2 (en) 2006-04-18 2009-11-03 Ekr Therapeutics, Inc. Pre-mixed, ready-to-use pharmaceutical compositions
US20080103169A1 (en) 2006-10-27 2008-05-01 The Curators Of The University Of Missouri Compositions comprising acid labile proton pump inhibiting agents, at least one other pharmaceutically active agent and methods of using same
US20090069418A1 (en) * 2007-04-25 2009-03-12 Alkayed Nabil J Compositions and Methods for the Treatment of Disorders Associated with Aberrant Vasodilation
DE102007054794A1 (de) * 2007-11-13 2009-05-14 Agilan Gmbh Wässrige Eisen-Dextran-Zubereitung mit ein oder mehreren Verbindungen der para-Hydroxy-Benzoesäureester und/oder deren Salzen
WO2009073665A1 (en) * 2007-12-03 2009-06-11 Signum Biosciences, Inc. Acid mimic compounds for the inhibition of isoprenyl-s-cysteinyl methyltransferase
AU2009215514B9 (en) 2008-02-20 2014-01-30 The Curators Of The University Of Missouri Composition comprising a combination of omeprazole and lansoprazole, and a buffering agent, and methods of using same
EP2570147B1 (en) 2008-06-13 2017-10-18 MannKind Corporation A dry powder inhaler and system for drug delivery
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
US9364619B2 (en) 2008-06-20 2016-06-14 Mannkind Corporation Interactive apparatus and method for real-time profiling of inhalation efforts
BRPI0913809B1 (pt) 2008-10-02 2019-02-05 Mylan Inc método para produzir continuamente um laminado adesivo sensível á pressão multicamada
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
TW201138782A (en) 2010-04-26 2011-11-16 Besins Healthcare Lu Sarl Low-oil pharmaceutical emulsion compositions comprising progestogen
RU2531455C2 (ru) 2010-06-21 2014-10-20 Маннкайнд Корпорейшн Системы и способы доставки сухих порошковых лекарств
KR101805087B1 (ko) 2010-09-16 2017-12-05 주식회사 엘지화학 높은 방부력을 제공하는 오일 주사 제형
CN105667994B (zh) * 2011-04-01 2018-04-06 曼金德公司 用于药物药盒的泡罩包装
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
US20130011494A1 (en) * 2011-07-10 2013-01-10 Mohammad Rahimi Composition for treating decubitus ulcers in diabetic and non-diabetic patients
CN102993031B (zh) 2011-09-19 2014-03-26 北京桑普生物化学技术有限公司 一种制备芳基多氧烷基季铵类化合物的方法
AU2012328885B2 (en) 2011-10-24 2017-08-31 Mannkind Corporation Methods and compositions for treating pain
CN108057154B (zh) 2012-07-12 2021-04-16 曼金德公司 干粉药物输送***和方法
US9925144B2 (en) 2013-07-18 2018-03-27 Mannkind Corporation Heat-stable dry powder pharmaceutical compositions and methods
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
DE102016000277A1 (de) 2016-01-15 2017-07-20 Beiersdorf Ag Kosmetische Zubereitungen enthaltend Benzethonium Chlorid und Diole
US11825842B2 (en) 2016-12-16 2023-11-28 Aurorium Holdings Llc Quaternary amine formulations and uses thereof
US11364225B2 (en) * 2019-08-21 2022-06-21 Bn Intellectual Properties, Inc. Pharmaceutical formulation for treating symptoms of migraine and cluster headaches, and method of using the same

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3489837A (en) 1968-07-11 1970-01-13 Leroy J Hyman Synergistic antiseptic composition consisting of 9-aminoacridine hydrochloride and benzethonium chloride
US4053628A (en) 1971-05-12 1977-10-11 Fisons Limited Composition
JPS6045849B2 (ja) 1980-08-25 1985-10-12 林原 健 ヒトエリトロポエチンの製造方法
US4506018A (en) 1982-12-30 1985-03-19 Becton, Dickinson And Company Blood diluent
US4703008A (en) 1983-12-13 1987-10-27 Kiren-Amgen, Inc. DNA sequences encoding erythropoietin
JPS6197229A (ja) 1984-10-18 1986-05-15 Chugai Pharmaceut Co Ltd 安定なエリトロポエチン製剤
JPH0651637B2 (ja) 1985-03-28 1994-07-06 エーザイ株式会社 ペプタイドの吸着防止組成物
US5045529A (en) * 1989-03-27 1991-09-03 Bionostics, Inc. Tonometric fluid for blood gas and co-oximetry instruments
JP3249147B2 (ja) 1990-06-01 2002-01-21 キリン−アムジエン・インコーポレーテツド 生理活性蛋白含有経口製剤
DE4126983A1 (de) 1991-08-15 1993-02-18 Boehringer Mannheim Gmbh Verfahren zur herstellung von humanprotein-enthaltenden, konservierten arzneimitteln fuer infusions- oder injektionszwecke
US5661125A (en) 1992-08-06 1997-08-26 Amgen, Inc. Stable and preserved erythropoietin compositions
ES2079320B1 (es) 1994-05-17 1996-10-16 Cusi Lab Disolucion oftalmica a base de un diclofenaco y tobramicina y sus aplicaciones.
US5611464A (en) 1995-05-30 1997-03-18 Ciba Geigy Corporation Container for preserving media in the tip of a solution dispenser
US5997893A (en) 1998-01-20 1999-12-07 Ethicon, Inc. Alcohol based anti-microbial compositions with cosmetic appearance
US6022551A (en) 1998-01-20 2000-02-08 Ethicon, Inc. Antimicrobial composition
AU777397B2 (en) 1999-07-22 2004-10-14 Aventisub Ii Inc. Multi-dose erythropoietin formulations
WO2001007086A1 (en) 1999-07-22 2001-02-01 Aventis Pharmaceuticals, Inc. Preserved pharmaceutical formulations

Also Published As

Publication number Publication date
NZ516736A (en) 2004-02-27
HUP0202235A2 (hu) 2002-11-28
HUP0202235A3 (en) 2004-05-28
AU777410C (en) 2006-08-17
HRP20020160A2 (en) 2003-10-31
CN1371287A (zh) 2002-09-25
US7109161B1 (en) 2006-09-19
NO20020304D0 (no) 2002-01-21
AU777410B2 (en) 2004-10-14
BR0012674A (pt) 2002-09-17
ZA200200743B (en) 2003-06-25
EA007070B1 (ru) 2006-06-30
IL147756A (en) 2005-12-18
CA2378892A1 (en) 2001-02-01
PL353026A1 (en) 2003-10-06
HK1050317A1 (zh) 2003-06-20
EP1200128A1 (en) 2002-05-02
KR20020032534A (ko) 2002-05-03
KR20070116181A (ko) 2007-12-06
NO20020304L (no) 2002-03-21
WO2001007086A1 (en) 2001-02-01
CZ2002265A3 (cs) 2002-08-14
IL147756A0 (en) 2002-08-14
AU6232500A (en) 2001-02-13
CA2378892C (en) 2008-07-15
JP2003520777A (ja) 2003-07-08
EE200200038A (et) 2003-04-15
EA200200072A1 (ru) 2003-02-27

Similar Documents

Publication Publication Date Title
YU4602A (sh) Farmaceutske formulacije zaštićene od dejstva mikroorganizama
HK1094320A1 (en) Antiseptic compositions, methods and systems
TW200744639A (en) Compositions comprising poorly water soluble pharmaceutical agents and antimicrobial agents
GEP20063885B (en) Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
MXPA05006685A (es) Antibioticos que contienen complejos de acido borinico y metodos de uso.
ITMI20041550A1 (it) Uso di batteri probiotici per la preparazione di composizioni topiche per la protezione dell'epidermide
ATE464055T1 (de) Topische zusammensetzungen mit phosphorylierten polyphenolen
PL1663168T3 (pl) Preparaty nikotyny i ich zastosowanie
AU2274201A (en) Compounds and compositions for delivering active agents
IL153297A0 (en) Compounds and compositions for delivering active agents
MY143795A (en) Tetrahydropyridoindole derivatives
MXPA01008611A (es) Compuestos y composiciones para suministrar agentes activos.
ATE326983T1 (de) Aminoalkohole enthaltende ophthalmische zusammensetzungen
UY26082A1 (es) Derivados de 1,4-diazabiciclo [3.2.2] nonan-4-carboxilato y -carboxamidas, su preparacion y su aplicacion en terapeutica
HK1088845A1 (en) Use of parthenolide derivatives as antileukemic and cytotoxic agents
MX2007006539A (es) Sistema para la absorcion percutanea mejorada de los agentes beneficiadores de la piel.
SE9900961D0 (sv) Novel compounds
AU3227700A (en) Skin sanitizing compositions
SE9802208D0 (sv) Novel compounds
MXPA04001256A (es) Productos de combinacion de derivados de propanolamina aril substituidos con otros ingredientes activos y su uso.
HK1098352A1 (en) Pharmaceutical composition comprising a zinc-hyaluronate complex for the treatment of multiple sclerosis
DK1228097T3 (da) Antimikrobiel aktivitet af den förste kationiske humane lactoferrin-klynge
MXPA05014184A (es) Utilizacion de acido hialuronico para la preparacion de composiciones para el tratamiento de aftas en la cavidad oral.
AU2001289714A1 (en) Benzofuran derivatives and their use as antibacterial agents
SE9802209D0 (sv) Novel compounds